secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001829126-25-002295
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc raises $1.6M placement; partners CBCC for India GBM trial
---------------------------------------------------------------

- Private placement gross proceeds ~$1.6M at $16/share for working capital.
- Strategic partnership with CBCC Global Research to enroll patients at 30 FDA-compliant sites in India.
- Partnership targets Phase 2a NEO100-01 GBM trial; enrollment completion expected this year, readout 6-8 months after.
- Financing is unregistered under Rule 506(b) to accredited investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625002295/0001829126-25-002295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625002295/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-002295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer